INVO News and Press, INVO BioScience Inc. From 03/24/23

INVO Bioscience Announces Pricing of $3.0 Million Registered Direct Offering Priced At-The-Market PR Newswire SARASOTA, Fla. , March 24, 2023 /PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focu...

2023-03-20 14:03:49 ET The definition of the term “penny stocks” includes shares of companies trading for under $5. While that is the generally accepted interpretation, most retail traders look for stocks trading for pennies, literally. In a stock market environment like the o...

2023-03-20 09:30:18 ET Nano-cap fertility company INVO Bioscience ( NASDAQ: INVO ) added ~24% pre-market Monday after announcing that it has agreed to acquire Wisconsin Fertility Institute, a provider of routine IVF procedures, in a transaction worth $10M in cash and stock...

INVO Signs Binding Agreements to Acquire Wisconsin Fertility Institute PR Newswire Accretive acquisition expected to add significant scale to INVO's operations Contributes  over $5 million in incremental annual revenue as well as positive net income ...

INVO Bioscience Enters Distribution Agreement for Taiwan PR Newswire SARASOTA, Fla. , Jan. 5, 2023 /PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access to advanced treatme...

INVO Bioscience Engages Nationally Recognized Physician for New Tampa-based INVO Center PR Newswire Shelly W. Holmström, M.D. FACOG, to serve as physician operator at soon to be opened Tampa -based INVO Center. The current metro area population of Tampa ...

First Baby Born in Malaysia Utilizing Innovative INVOcell Assisted Reproductive Technology PR Newswire Patient was part of a prospective peer reviewed study of INVOcell compared to conventional IVF (cIVF) in Malaysia INVOcell provides an advanced, effective and a...

INVO Bioscience, Inc. (INVO) Q3 2022 Earnings Conference Call November 14, 2022, 4:30 PM ET Company Participants Robert Blum - Lytham Partners, IR Steven Shum - Chief Executive Officer Mike Campbell - Chief Operating Officer and VP, Business Development Andre...

INVO BioScience press release ( NASDAQ: INVO ): Q3 GAAP EPS of -$0.21 misses by $0.09 . Revenue of $0.24M (+9.1% Y/Y) beats by $0.01M . As of September 30, 2022, the Company had approximately $0.3 million in cash. Shares +0.84% . For further detai...

INVO Bioscience Reports Third Quarter 2022 Financial Results PR Newswire Company to Host Conference Call Today at 4:30pm ET SARASOTA, Fla. , Nov. 14, 2022 /PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a co...